Replies to post #291836 on NorthWest Biotherapeutics Inc (NWBO)

[iwasadiver]

You’re completely correct on this. The whole reason the FDA did their guidance in December was to accommodate NWBO and DCVax-L. However, that guidance was simply for the icing on the cake of the SAP. There will be all kinds of data available that will show where NWBO is heading and why they’re going in that direction. I believe the “market” will be stunned, and I believe the world of Oncology already knows what’s coming and are anticipating it widely.

[sukus]

Great post Survivor!

[sentiment_stocks]

Think about the extreme case where two curves track the same up to the 50% mark and for what ever reason 49% of patients live 10 years and the curve is completely flat out to right in the treatment arm and in the control arm they all pass away shortly after the median with the curve getting steeper after the median. Would this not be a great success? I think it would. Would you take a drug if you had a 49/51% chance of being cured?

So do you mean when the chart ends up looking like this one?



Some may remember this lovely chart that I drew several years back, lol. :)

[biosectinvestor]

I think, once they learn more as they treat more patients, assuming it gets approved on your lesser scenario, that in combination with other drugs, they may likely extend out the patients that are most assisted by DCVax until it represents a significantly larger percentage of the population today.

Obviously, that’s an informed hypothesis, based upon looking at the other treatments both approved already and those coming along. I think we will advance in cancer treatments, based upon a multiple drug and multiple biological approach until most patients live much longer. And certainly that is, at the least, a strong hope.